Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Sherwin

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reports|May 1, 1986
Phase I trial of recombinant interferon gamma by 1-hour i.v. infusionS Vadhan-Raj, C F Nathan, S A Sherwin, et al.
Cancer Research|August 1, 1984
Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individualsE S Kimball, W H Bohn, K D Cockley, et al.
Journal of Biological Response Modifiers|January 1, 1983
Changes in immune function in patients receiving natural leukocyte interferonA E Maluish, J R Ortaldo, S A Sherwin, et al.
Cancer Research|May 1, 1985
Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic miceD R Twardzik, E S Kimball, S A Sherwin, et al.
Cancer|May 15, 1989
Recombinant interferon-gamma lacks activity against metastatic colorectal cancer but increases serum levels of CA 19-9M J O'Connell, R A Ritts, C G Moertel, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanomaE T Creagan, D L Ahmann, H J Long, et al.
The New England Journal of Medicine|January 5, 1984
Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoidesS D Averbuch, H A Austin, S A Sherwin, et al.
Cancer Treatment Reports|February 1, 1987
Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomasJ H Edmonson, H J Long, E T Creagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patientsR Kurzrock, M G Rosenblum, J R Quesada, et al.
The American Journal of Medicine|August 1, 1984
Recombinant alpha interferon in retreatment of two patients with pulmonary lymphoma. Dramatic responses with resolution of pulmonary complicationsH C Stevenson, J J Ochs, L Halverson, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reports|May 1, 1986
Phase I trial of recombinant interferon gamma by 1-hour i.v. infusionS Vadhan-Raj, C F Nathan, S A Sherwin, et al.
Cancer Research|August 1, 1984
Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individualsE S Kimball, W H Bohn, K D Cockley, et al.
Journal of Biological Response Modifiers|January 1, 1983
Changes in immune function in patients receiving natural leukocyte interferonA E Maluish, J R Ortaldo, S A Sherwin, et al.
Cancer Research|May 1, 1985
Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic miceD R Twardzik, E S Kimball, S A Sherwin, et al.
Cancer|May 15, 1989
Recombinant interferon-gamma lacks activity against metastatic colorectal cancer but increases serum levels of CA 19-9M J O'Connell, R A Ritts, C G Moertel, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanomaE T Creagan, D L Ahmann, H J Long, et al.
The New England Journal of Medicine|January 5, 1984
Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoidesS D Averbuch, H A Austin, S A Sherwin, et al.
Cancer Treatment Reports|February 1, 1987
Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomasJ H Edmonson, H J Long, E T Creagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patientsR Kurzrock, M G Rosenblum, J R Quesada, et al.
The American Journal of Medicine|August 1, 1984
Recombinant alpha interferon in retreatment of two patients with pulmonary lymphoma. Dramatic responses with resolution of pulmonary complicationsH C Stevenson, J J Ochs, L Halverson, et al.
Pageof 6